Providence Regional Medical Center Everett

Recent papers from Providence Regional Medical Center Everett

1. Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trialThe Lancet · 2026
2. Effects of semaglutide on kidney disease in type 2 diabetes: a randomized placebo-controlled trialNature Medicine · 2026
3. Calling Attention to Underrecognized RiskJournal of the American College of Cardiology · 2026
4. SGLT Inhibitors for Heart and Kidney Disease in Type 1 DiabetesDiabetes Care · 2026
5. Leveraging Google location history data to assess the impact of activities, locations, and time spent in green space on mental health during the COVID-19 pandemicAmerican Journal of Epidemiology · 2026
6. SGLT2 inhibition modulates metabolic, vascular, and inflammatory molecular markers in the kidney in youth with type 1 diabetesScience Translational Medicine · 2026
7. A qualitative exploration of clinicians’ experiences and perceptions of a well-being leadership development training programBMC Health Services Research · 2026
8. Targeting IL-6 for Treatment of Chronic Kidney Disease and Cardiovascular DiseaseKidney International Reports · 2026
9. International Society of Nephrology International Expert Forum: Exploring the Nexus of Cardiovascular-Kidney-Metabolic HealthKidney International · 2026
10. Abdominal waist circumference and subcutaneous adipose tissue thickness predicts development of post-transplant diabetes mellitusInternational Urology and Nephrology · 2026
11. Comparison of Specific Glucagon-Like Peptide-1 Receptor Agonists on Kidney Outcomes Among Patients With Type 2 DiabetesAmerican Journal of Kidney Diseases · 2026
12. Targeted reflex RNA sequencing for enhanced variant classification on exome and genome sequencing improves patient outcomesnpj Genomic Medicine · 2026
13. Comparative effectiveness of sulfonylureas on kidney outcomes in adults with type 2 diabetes and moderate cardiovascular risk: a target trial emulationBMJ Open Diabetes Research & Care · 2026
14. Comparative Effectiveness of Individual Sodium Glucose Transporter 2 Inhibitors on Cardiovascular Outcomes in Type 2 Diabetes With Moderate Cardiovascular Risk: Emulation of a Target TrialJournal of the American Heart Association · 2026
15. When you see a green (white) service robotic dog: the roles of color, message framing, and service encounter in promoting sustainable practicesJournal of Hospitality and Tourism Insights · 2026
16. A Pilot Evaluation of a Telemedicine Pharmacist–Physician Management Model to Increase Access to Medication for Alcohol and Opioid Use Disorders for Rural VeteransThe Journal of Rural Health · 2026
17. Acute Estimated Glomerular Filtration Rate Decline After Initiation of Therapies That Slow Kidney Disease Progression: Clinical Practice ImplicationsMayo Clinic Proceedings · 2026
18. RAAS blockade in the kidney Life-Cycle - Treatment StandardNephrology Dialysis Transplantation · 2026
19. Pre-heart failure in early chronic kidney disease: clinical epidemiology and treatmentEuropean Heart Journal · 2026
20. Leadership Perspectives From Respiratory Therapy LeadersRespiratory Care · 2024